These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35626327)

  • 21. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter analytical performance evaluation of the Elecsys proBNP assay.
    Sokoll LJ; Baum H; Collinson PO; Gurr E; Haass M; Luthe H; Morton JJ; Nowatzke W; Zingler C
    Clin Chem Lab Med; 2004; 42(8):965-72. PubMed ID: 15387451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL
    J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.
    Prontera C; Zucchelli GC; Vittorini S; Storti S; Emdin M; Clerico A
    Clin Chim Acta; 2009 Feb; 400(1-2):70-3. PubMed ID: 18992732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
    Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010.
    Di Serio F; Ruggieri V; Varraso L; De Sario R; Mastrorilli A; Pansini N
    Clin Chem Lab Med; 2005; 43(11):1263-73. PubMed ID: 16232094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood.
    Zugck C; Nelles M; Katus HA; Collinson PO; Gaze DC; Dikkeschei B; Gurr E; Hayen W; Haass M; Hechler C; van Hoof V; Guerti K; van Waes C; Printzen G; Klopprogge K; Schulz I; Zerback R
    Clin Chem Lab Med; 2006; 44(10):1269-77. PubMed ID: 17032141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.
    Saenger AK; Rodriguez-Fraga O; Ler R; Ordonez-Llanos J; Jaffe AS; Goetze JP; Apple FS
    Clin Chem; 2017 Jan; 63(1):351-358. PubMed ID: 28062628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
    Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
    Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
    Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
    JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
    Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
    Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays].
    Cauliez B; Boucher S; Duflo-Leroy A; Lavoinne A
    Ann Biol Clin (Paris); 2007; 65(1):93-8. PubMed ID: 17264046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery?
    Ushirozako H; Ohishi T; Fujita T; Suzuki D; Yamamoto K; Banno T; Takase H; Matsuyama Y
    Clin Orthop Relat Res; 2017 Jun; 475(6):1730-1736. PubMed ID: 28101755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
    Fuat A; Murphy JJ; Hungin AP; Curry J; Mehrzad AA; Hetherington A; Johnston JI; Smellie WS; Duffy V; Cawley P
    Br J Gen Pract; 2006 May; 56(526):327-33. PubMed ID: 16638247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.